We're sorry, but we couldn't find any results that match your search criteria. Please try again with different keywords or filters.
Loading
1:00 PM – 5:00 PM
(PST)
-
Session
7:00 AM – 5:30 PM
(PST)
-
Session
1:00 AM – 2:00 AM
(PST)
-
CP
- Cell and Gene Therapy and Genome Editing
-
CP
- Cell and Gene Therapy and Genome Editing
-
CP
- Cell and Gene Therapy and Genome Editing
-
CP
- Oncology
-
CP
- Cell and Gene Therapy and Genome Editing
-
CP
- Oncology
-
CP
- Other
-
CP
- CNS/Neurological
-
CP
- Oncology
-
CP
- Dermatology
-
CP
- Multiple Therapeutics
-
CP
- Oncology
-
CP
- Medical Devices
-
CP
- Immunology
-
CP
- CNS/Neurological
-
CP
- Immunology
-
CP
- Cell and Gene Therapy and Genome Editing
-
CP
- Metabolic Diseases
-
CP
- Food and Agriculture
-
CP
- Orphan and Rare Disease
-
CP
- Oncology
-
CP
- Platform for Therapeutics
-
CP
- Oncology
-
CP
- Oncology
-
CP
- Oncology
-
CP
- Dermatology
-
CP
- Inflammation
-
CP
- Oncology
-
CP
- Metabolic Diseases
-
CP
- Platform for Therapeutics
-
CP
- CNS/Neurological
-
CP
- CNS/Neurological
-
CP
- Oncology
-
CP
- Tools/Drug Development Support Tech
-
CP
- CNS/Neurological
-
CP
- Cell and Gene Therapy and Genome Editing
-
CP
- Multiple Therapeutics
-
CP
- Animal Health Products
-
CP
- Oncology
-
CP
- CNS/Neurological
-
CP
- Ophthalmology
-
CP
- Multiple Therapeutics
-
CP
- Multiple Therapeutics
-
CP
- Multiple Therapeutics
-
CP
- Pain Management
-
CP
- Oncology
-
CP
- Multiple Therapeutics
-
CP
- Oncology
-
CP
- Cardiovascular
-
CP
- Multiple Therapeutics
-
CP
- Cell and Gene Therapy and Genome Editing
-
CP
- Infectious Disease and Vaccines
-
CP
- Platform for Therapeutics
-
CP
- Cell and Gene Therapy and Genome Editing
-
CP
- Multiple Therapeutics
-
CP
- Cell and Gene Therapy and Genome Editing
-
CP
- Immunology
-
Company Presentation
-
CP
- Platform for Therapeutics
-
CP
- Cell and Gene Therapy and Genome Editing
-
CP
- Tools/Drug Development Support Tech
-
CP
- Oncology
-
CP
- Multiple Therapeutics
-
CP
- Platform for Therapeutics
-
CP
- Reproductive/Sexual Health
-
CP
- Tools/Drug Development Support Tech
-
CP
- Dermatology
-
CP
- Oncology
-
CP
- Pain Management
-
CP
- Platform for Therapeutics
-
CP
- CNS/Neurological
-
CP
- Cell and Gene Therapy and Genome Editing
-
CP
- Inflammation
-
CP
- Oncology
-
CP
- Ophthalmology
-
CP
- Oncology
-
CP
- Immunology
-
CP
- Multiple Therapeutics
-
CP
- Inflammation
-
CP
- Metabolic Diseases
-
CP
- Orphan and Rare Disease
-
CP
- Regenerative Medicine
-
CP
- Gastrointestinal
-
CP
- Cell and Gene Therapy and Genome Editing
-
CP
- CNS/Neurological
-
CP
- Metabolic Diseases
-
CP
- Multiple Therapeutics
-
CP
- Cell and Gene Therapy and Genome Editing
-
CP
- Ophthalmology
-
CP
- Multiple Therapeutics
-
CP
- Diagnostics and Personalized Medicine
-
CP
- Multiple Therapeutics
-
CP
- Cell and Gene Therapy and Genome Editing
-
CP
- Cell and Gene Therapy and Genome Editing
-
CP
- Oncology
-
CP
- Immunology
-
CP
- Oncology
-
CP
- Oncology
-
CP
- Oncology
-
CP
- Multiline Global Biopharma
-
CP
- Immunology
-
CP
- CNS/Neurological
-
CP
- Multiple Therapeutics
-
CP
- CNS/Neurological
-
CP
- Multiple Therapeutics
-
CP
- Regenerative Medicine
-
CP
- Infectious Disease and Vaccines
-
CP
- CNS/Neurological
-
CP
- Cell and Gene Therapy and Genome Editing
-
CP
- Orphan and Rare Disease
-
CP
- Platform for Therapeutics
-
CP
- Respiratory
-
CP
- Immunology
-
CP
- Diagnostics and Personalized Medicine
-
CP
- Regenerative Medicine
-
CP
- Cardiovascular
-
CP
- Multiple Therapeutics
-
CP
- Cell and Gene Therapy and Genome Editing
-
CP
- Inflammation
-
CP
- Platform for Therapeutics
-
CP
- CNS/Neurological
-
CP
- Medical Devices
-
CP
- CNS/Neurological
-
CP
- CNS/Neurological
-
CP
- Tools/Drug Development Support Tech
-
CP
- Platform for Therapeutics
-
CP
- Regenerative Medicine
-
CP
- Oncology
-
CP
- Orphan and Rare Disease
-
CP
- Multiple Therapeutics
-
CP
- Ophthalmology
-
CP
- Oncology
-
CP
- Immunology
-
CP
- Oncology
-
CP
- Dermatology
-
CP
- AI and Digital Health
-
CP
- Multiple Therapeutics
-
CP
- Cell and Gene Therapy and Genome Editing
-
CP
- Multiple Therapeutics
-
CP
- Infectious Disease and Vaccines
-
CP
- Platform for Therapeutics
-
CP
- Cell and Gene Therapy and Genome Editing
-
CP
- Ophthalmology
-
CP
- CNS/Neurological
-
CP
- CNS/Neurological
-
CP
- CNS/Neurological
-
CP
- Multiple Therapeutics
-
CP
- Oncology
-
CP
- Cell and Gene Therapy and Genome Editing
-
CP
- Inflammation
-
CP
- Oncology
-
CP
- Cell and Gene Therapy and Genome Editing
-
CP
- Oncology
-
CP
- Oncology
-
CP
- Multiple Therapeutics
-
CP
- Cell and Gene Therapy and Genome Editing
-
CP
- Platform for Therapeutics
-
CP
- Tools/Drug Development Support Tech
-
CP
- Oncology
-
CP
- Cardiovascular
-
CP
- Platform for Therapeutics
-
CP
- Oncology
-
CP
- Orphan and Rare Disease
-
CP
- Oncology
-
CP
- Medical Devices
-
CP
- Cardiovascular
-
CP
- CNS/Neurological
-
CP
- Oncology
-
CP
- Cell and Gene Therapy and Genome Editing
-
CP
- Cell and Gene Therapy and Genome Editing
-
CP
- CNS/Neurological
-
CP
- Oncology
-
CP
- Platform for Therapeutics
-
CP
- Oncology
-
CP
- Oncology
-
CP
- Infectious Disease and Vaccines
-
CP
- Other
-
CP
- Platform for Therapeutics
-
CP
- Regenerative Medicine
-
CP
- Oncology
-
CP
- Multiple Therapeutics
-
CP
- Cell and Gene Therapy and Genome Editing
-
CP
- Cardiovascular
-
CP
- Inflammation
-
CP
- Oncology
-
CP
- Immunology
-
CP
- CNS/Neurological
-
CP
- CNS/Neurological
-
CP
- Cell and Gene Therapy and Genome Editing
-
CP
- CNS/Neurological
-
CP
- Tools/Drug Development Support Tech
-
CP
- CNS/Neurological
-
CP
- Oncology
-
CP
- Platform for Therapeutics
-
CP
- Infectious Disease and Vaccines
-
CP
- Multiple Therapeutics
-
CP
- Regenerative Medicine
-
CP
- Immunology
-
CP
- CNS/Neurological
-
CP
- Oncology
-
CP
- Other
-
CP
- Platform for Therapeutics
-
CP
- Cell and Gene Therapy and Genome Editing
-
CP
- Platform for Therapeutics
-
CP
- Respiratory
-
CP
- Medical Devices
-
CP
- Oncology
-
CP
- Regenerative Medicine
-
CP
- Pain Management
-
CP
- Multiple Therapeutics
-
CP
- Immunology
-
CP
- Oncology
-
CP
- Other
-
CP
- Cardiovascular
-
CP
- CNS/Neurological
-
CP
- Immunology
-
CP
- Animal Health Products
-
CP
- Other
-
CP
- Other
6:30 AM – 7:00 PM
(PST)
-
Session
-
Session
9:00 AM – 12:00 PM
(PST)
-
Breakout Session
- Infectious Disease and Vaccines
9:05 AM – 9:40 AM
(PST)
9:45 AM – 10:40 AM
(PST)
10:00 AM – 11:00 AM
(PST)
-
Breakout Session
- Asia-Pacific Opportunities
10:45 AM – 11:30 AM
(PST)
11:35 AM – 11:55 AM
(PST)
12:00 PM – 1:00 PM
(PST)
-
Breakout Session
- Asia-Pacific Opportunities
1:45 PM – 2:45 PM
(PST)
-
Breakout Session
- Next Generation Biotherapeutics
-
Breakout Session
- Business Development and Finance
-
Breakout Session
- Business Development and Finance
-
Breakout Session
- Patient Advocacy
-
Breakout Session
- AI and Digital Health
-
Breakout Session
- Asia-Pacific Opportunities
-
Breakout Session
- Emerging Opportunities in Global Markets
-
Super SessionSuper Session
- Business Development and Finance
-
Breakout Session
- Cell and Gene Therapy and Genome Editing
-
Breakout Session
- Regulatory Innovation
-
Breakout Session
- Infectious Disease and Vaccines
3:00 PM – 4:00 PM
(PST)
-
Breakout Session
- Patient Advocacy
-
Breakout Session
- Cell and Gene Therapy and Genome Editing
-
Breakout Session
- Regulatory Innovation
-
Breakout Session
- Business Development and Finance
-
Breakout Session
- Business Development and Finance
-
Breakout Session
- Emerging Opportunities in Global Markets
-
Fireside ChatFireside Chat
- Business Development and Finance
-
Fireside ChatFireside Chat
- Next Generation Biotherapeutics
-
Breakout Session
- Infectious Disease and Vaccines
-
Breakout Session
- Next Generation Biotherapeutics
-
Breakout Session
- Asia-Pacific Opportunities
4:15 PM – 5:15 PM
(PST)
-
Breakout Session
- Business Development and Finance
-
Breakout Session
- Regulatory Innovation
-
Breakout Session
- Infectious Disease and Vaccines
-
Breakout Session
- Business Development and Finance
-
Fireside ChatFireside Chat
- Business Development and Finance
-
Special Program
- Regulatory Innovation
-
Breakout Session
- Business Development and Finance
-
Breakout Session
- Cell and Gene Therapy and Genome Editing
-
Breakout Session
- Asia-Pacific Opportunities
-
Breakout Session
- Emerging Opportunities in Global Markets
-
Breakout Session
- Next Generation Biotherapeutics
7:00 PM – 9:00 PM
(PST)
-
Session
6:30 AM – 6:30 PM
(PST)
-
Session
10:30 AM – 4:10 PM
(PST)
-
BioProcess BioProcess Theater
11:00 AM – 12:00 PM
(PST)
-
Breakout Session
- AI and Digital Health
-
Breakout Session
- Cell and Gene Therapy and Genome Editing
-
Breakout Session
- Business Development and Finance
-
Breakout Session
- Business Development and Finance
-
Special Program
- Regulatory Innovation
-
BP BioProcess Theater
-
Breakout Session
- Business Development and Finance
-
Breakout Session
- Next Generation Biotherapeutics
-
Breakout Session
- Clinical Trials Innovations
-
Breakout Session
- Brain Health
12:00 PM – 12:10 PM
(PST)
-
BP BioProcess Theater
12:10 PM – 12:20 PM
(PST)
12:15 PM – 1:30 PM
(PST)
-
Super SessionSuper Session
- Emerging Opportunities in Global Markets
12:20 PM – 1:00 PM
(PST)
1:00 PM – 1:30 PM
(PST)
1:30 PM – 2:45 PM
(PST)
-
Special Program 29AB
1:45 PM – 2:45 PM
(PST)
-
Breakout Session
- Cell and Gene Therapy and Genome Editing
-
Breakout Session
- AI and Digital Health
-
Breakout Session
- Intellectual Property
-
Fireside ChatFireside Chat
- Business Development and Finance
-
Breakout Session
- Business Development and Finance
-
NIH Support for Minority Health and Health Disparities Focused on Early-Stage Life Science CompaniesBreakout Session
- Diversity‚ Equity and Inclusion
-
Breakout Session
- Business Development and Finance
-
Breakout Session
- Brain Health
-
Breakout Session
- Infectious Disease and Vaccines
-
Special Program
- Business Development and Finance
2:00 PM – 3:00 PM
(PST)
3:00 PM – 4:00 PM
(PST)
-
Breakout Session
- Brain Health
-
Breakout Session
- Environmental Sustainability
-
Fireside ChatFireside Chat
- Business Development and Finance
-
Breakout Session
- Business Development and Finance
-
Breakout Session
- Next Generation Biotherapeutics
-
Breakout Session
- Business Development and Finance
-
Breakout Session
- Cell and Gene Therapy and Genome Editing
-
Super SessionSuper Session
- Next Generation Biotherapeutics
-
Breakout Session
- Business Development and Finance
-
Breakout Session
- Diversity‚ Equity and Inclusion
3:20 PM – 3:40 PM
(PST)
3:40 PM – 4:10 PM
(PST)
4:15 PM – 5:15 PM
(PST)
-
Breakout Session
- Environmental Sustainability
-
Breakout Session
- Intellectual Property
-
Breakout Session
- Business Development and Finance
-
Breakout Session
- Business Development and Finance
-
Breakout Session
- Brain Health
-
Breakout Session
- Cell and Gene Therapy and Genome Editing
-
Super SessionSuper Session
- Business Development and Finance
-
Breakout Session
- Next Generation Biotherapeutics
-
Breakout Session
- Diversity‚ Equity and Inclusion
-
Breakout Session
- Diagnostics and Personalized Medicine
-
Fireside Chat
5:00 PM – 6:30 PM
(PST)
-
Session
6:30 AM – 7:00 PM
(PST)
-
Session
9:00 AM – 10:30 AM
(PST)
10:30 AM – 4:10 PM
(PST)
-
BioProcess BioProcess Theater
11:00 AM – 12:00 PM
(PST)
-
Achieving Commercial Success Through the National Institutes of Health's Intramural Research ProgramBreakout Session
- Business Development and Finance
-
Breakout Session
- Business Development and Finance
-
Breakout Session
- Orphan and Rare Disease
-
Breakout Session
- Business Development and Finance
-
Breakout Session
- Translational Research
-
Breakout Session
- Diversity‚ Equity and Inclusion
-
Breakout Session
- Environmental Sustainability
-
Breakout Session
- AI and Digital Health
12:00 PM – 12:10 PM
(PST)
12:10 PM – 12:20 PM
(PST)
12:20 PM – 1:00 PM
(PST)
1:00 PM – 1:30 PM
(PST)
1:30 PM – 2:45 PM
(PST)
-
Special Program 29AB
1:45 PM – 2:45 PM
(PST)
-
Breakout Session
- Translational Research
-
Breakout Session
- AI and Digital Health
-
Breakout Session
- Environmental Sustainability
-
Breakout Session
- Business Development and Finance
-
Breakout Session
- Cell and Gene Therapy and Genome Editing
-
Breakout Session
- Orphan and Rare Disease
-
Breakout Session
- Diversity‚ Equity and Inclusion
-
Breakout Session
- AI and Digital Health
-
Breakout Session
- Oncology
2:00 PM – 3:00 PM
(PST)
3:00 PM – 4:00 PM
(PST)
-
Breakout Session
- Oncology
-
Breakout Session
- Business Development and Finance
-
Breakout Session
- Diversity‚ Equity and Inclusion
-
Breakout Session
- Business Development and Finance
-
Breakout Session
- Environmental Sustainability
-
Breakout Session
- Translational Research
-
Breakout Session
- Value‚ Patient Access and Reimbursement
-
Breakout Session
- Oncology
-
Breakout Session
- AI and Digital Health
-
Breakout Session
- Infectious Disease and Vaccines
3:20 PM – 3:30 PM
(PST)
3:30 PM – 3:40 PM
(PST)
3:40 PM – 4:10 PM
(PST)
4:15 PM – 5:15 PM
(PST)
-
Breakout Session
- Infectious Disease and Vaccines
-
Breakout Session
- Diversity‚ Equity and Inclusion
-
Breakout Session
- Value‚ Patient Access and Reimbursement
-
Breakout Session
- Business Development and Finance
-
Breakout Session
- Translational Research
-
Breakout Session
- AI and Digital Health
-
Breakout Session
- Diagnostics and Personalized Medicine
7:00 PM – 9:00 PM
(PST)
-
Session
6:30 AM – 4:30 PM
(PST)
-
Session
9:00 AM – 10:00 AM
(PST)
-
Breakout Session
- Infectious Disease and Vaccines
-
Breakout Session
- Business Development and Finance
-
Immune System Biomarkers: Can Our Antibodies Predict How We Will React to Disease and Immunotherapy?Breakout Session
- Diagnostics and Personalized Medicine
-
Breakout Session
- Oncology
-
Breakout Session
- Clinical Trials Innovations
-
Breakout Session
- Business Development and Finance
-
Breakout Session
- Regulatory Innovation
-
Breakout Session
- Oncology
10:15 AM – 11:15 AM
(PST)
-
Breakout Session
- Regulatory Innovation
-
Breakout Session
- Oncology
-
Breakout Session
- Infectious Disease and Vaccines
-
Breakout Session
- Diagnostics and Personalized Medicine
-
Breakout Session
- Business Development and Finance
-
Breakout Session
- Oncology
-
Breakout Session
- Business Development and Finance
3:00 PM – 4:00 PM
(PST)
-
Session